ClearLLab Antibody Solutions
Beckman Coulter is revolutionizing the leukemia and lymphoma analysis in clinical flow cytometry laboratories with the innovative ClearLLab Solutions:
- ClearLLab 10C system is an integrated FDA cleared and CE-marked IVD leukemia and lymphoma* (L&L) immunophenotyping solution for lymphoid and myeloid lineages using the dry DURA Innovations technology
- ClearLLab Control Cells are the first application specific control cells for L&L immunophenotyping
- ClearLLab Reagents are the first 5-color panels to receive US Food and Drug Administration (FDA) clearance (via the De Novo Process) for L&L flow cytometric immunophenotyping in the clinical lab.
*For Non-Hodgkin’s lymphoma only
ClearLLab 10C System
ClearLLab 10C is the only integrated IVD L&L immunophenotyping solution for lymphoid and myeloid lineages, which includes the ClearLLab 10-color panels, compensation setup kits, application specific ClearLLab Control Cells and the Kaluza C analysis software, validated on the Navios or Navios EX flow cytometer.
ClearLLab Control Cells
ClearLLab Control Cells, a liquid preparation of stabilized human erythrocytes and leukocytes (lymphocytes monocytes and granulocytes), are the first application specific IVD controls cells for L&L immunophenotyping. ClearLLab Control Cells are available as normal phenotype and as abnormal phenotype. They are intended for use with the ClearLLab 10C panels.
ClearLLab Compensation Kit
The ClearLLab Compensation Kit may be used with the ClearLLab Compensation Beads for ClearLLab 10C and with the CYTO-COMP Cell Kit, with normal whole blood for ClearLLab LS (only available outside of US). It is used to adjust color compensation settings on a Navios and Navios EX flow cytometer with standard filter set and equipped with AutoSetup software, prior to multi-color analysis.
ClearLLab LS Lymphoid Screen
ClearLLab LS Lymphoid Screen antibody panel was the first CE-IVD-marked 10-color assay for leukemia* and lymphoma analysis. ClearLLab LS has been specifically designed for the fast and accurate identification of haematolymphoid cell populations on the company’s Navios and Navios EX flow cytometers.
ClearLLab 5C Reagents
ClearLLab Reagents are the first reagents to receive US Food and Drug Administration (FDA) clearance for leukemia and lymphoma* flow cytometric immunophenotyping. ClearLLab reagents have been specifically designed for the fast and accurate identification of a number of haematolymphoid cell populations on the FC500 flow cytometer.